Full-Time

Associate Scientist

Microbiology

Updated on 9/12/2026

Deadline 8/24/27
Alcami

Alcami

51-200 employees

Pharmaceutical and biologics CDMO services

No salary listed

Wilmington, NC, USA

In Person

100% on-site; Wednesday–Saturday, 8:00 a.m.–6:30 p.m.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Microsoft Office
ERP
Microbiology

Get referred to Alcami

See people who can refer or advise you

Requirements
  • A bachelor's degree in Biology, Microbiology, or a related field.
  • 0–4+ years of related work experience.
  • Aseptic technique.
  • Experience with sterility testing within an isolator using traditional and rapid methods.
  • Microbial identification using a genetic sequencer.
  • Kinetic endotoxin testing using 96-well plate readers and multi-cartridge systems.
  • Microbial examination and in-process bioburden testing.
  • Method validation for endotoxin, sterility, and microbial examination.
  • Growth promotion testing.
  • Media fill support.
  • Sub-visible particulate matter testing.
  • Familiarity with good manufacturing practice regulations.
  • General working knowledge of Microsoft Office applications.
  • Moderate familiarity with classes of organisms.
  • Basic knowledge of microbial taxonomy procedures.
  • Ability to recognize procedural deviations and the need for investigations.
  • Ability to independently execute routine testing with little to no supervision and perform more complex methods with supervision.
  • Ability to collaborate with microbiology, environmental monitoring, chemistry, and manufacturing personnel.
  • Ability to organize tasks and ensure timely completion.
  • Ability to travel up to 5%.
Responsibilities
  • Perform complex microbial analysis and microbiological testing to support the sterile manufacturing facility and external clients.
  • Perform microbiological testing of raw material, in-process, and finished product samples, including microbial examination, in-process bioburden, kinetic endotoxin, sterility testing, sub-visible particulate matter testing, microbial in-use studies, and media fill qualifications.
  • Isolate and culture bacteria and other microorganisms in prescribed media while controlling moisture, aeration, temperature, and nutrition.
  • Examine physiological, morphological, and cultural characteristics using a microscope and other relevant equipment to identify and classify microorganisms in test articles.
  • Manage sample incubation, plate reading, and reporting of results.
  • Complete assigned good manufacturing practice reviews accurately.
  • Maintain working knowledge of instrumentation, equipment, and scientific methodologies required for assigned tasks.
  • Use the electronic laboratory notebook system to perform and document testing and results.
  • Use company tools to track project progress through the enterprise resource planning system and track samples through chain-of-command software.
  • Participate in company training and maintain current certification status.
  • Review and revise procedures as requested.
  • Complete required testing documentation in accordance with company policies and procedures.
  • Support laboratory safety and cleanliness by maintaining inventory, disposing of waste, and routinely cleaning laboratory rooms and equipment.
  • Provide problem-solving support and own laboratory investigation reports for the Microbiology Department.
Desired Qualifications
  • Prior laboratory experience or work experience in pharmaceutical, contract development and manufacturing organization, or good manufacturing practice environments.
  • Experience with microbial genetic identification using a MicroSeq system.
  • Experience with kinetic endotoxin testing using a 96-well plate reader.
  • Experience with growth promotion testing.
  • Experience with microbial method development and validation.

Alcami is a contract development and manufacturing organization supporting pharmaceutical and biologics companies from early development through commercial production. Services span drug product manufacturing (sterile fill-finish and oral solid dose), analytical and microbiology lab testing, and cGMP storage with validation and environmental monitoring. What sets Alcami apart is its integrated, end-to-end capabilities across the development lifecycle. The goal is to help pharma and biotech partners deliver safe, high-quality therapies to patients.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Pepperell, Massachusetts

Founded

1984

Get referred to Alcami

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Alcami acquired Tjoapack on May 5, 2026, expanding packaging reach into the Netherlands.
  • January 19, 2026 Durham facility purchase deepens biologics capacity for advanced services.
  • Revelio reported 1,038 employees in March 2026, showing hiring despite CEO turnover.

What critics are saying

  • February 6, 2026 FDA 483 at Charleston flagged sterile manufacturing controls and investigations.
  • Tjoapack integration strains management through 2026, with packaging line delivery only in 2027.
  • A sterile quality failure could shut Charleston operations and imperil Alcami's CDMO credibility.

What makes Alcami unique

  • Patrick Walsh keeps Alcami founder-level operator continuity after January 2025 CEO transition.
  • Durham RTP expansion adds fifth GMP fill-finish line and broad biologics analytical capacity.
  • Six-site U.S. GMP storage network gives Alcami integrated storage, testing, and manufacturing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

PR Newswire
Jan 13th, 2025
Alcami Announces Ceo Transition

Long time industry leader, Chairman of the Board Patrick Walsh replaces CEO Bill Humphries DURHAM, N.C., Jan. 13, 2025 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the resignation of Bill Humphries. Alcami's Board Chair and former Chief Executive Officer Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations and a strong client-centric approach from a proven industry veteran

PR Newswire
Jul 23rd, 2024
Alcami Unveils New Conditions And Services At State-Of-The-Art Pharma Storage Facility In Garner

"Alcami's new facility is well positioned to fill previously unmet market demand," said Laurent Boer, President, Alcami Pharma Storage and Services. "The pipeline of complex medicines – exactly the type of ground-breaking products that life science companies in RTP work on – is only increasing. The biopharmaceutical materials and products in these drugs require very specific warehouse conditions that this new facility provides. But what truly sets us apart as a CDMO is our ability to offer a comprehensive pharma storage network paired with seamless access to our integrated laboratory and manufacturing services. From development to delivery, Alcami has the capabilities to care for and secure product within our own network, reducing risk and streamlining efficiency."After opening in January with controlled/ambient storage, the facility can now accept shipments for an extensive range of storage conditions, including stability chamber storage, refrigerated storage, freezer, ultra-low freezer, and cryogenic storage (LN2) as well as custom conditions. In addition, the site now offers a full suite of materials management and support services that facilitate the full product development, storage, and commercialization journey, including onsite aliquoting/sampling in grade C sampling booths, refrigerated transport, labeling, cycle counting/inventory management, custom kitting, and reference standards management.The new central North Carolina facility adjacent to the Research Triangle Park expands Alcami's high-quality, secure GMP storage network to six U.S

Contract Pharma
Dec 15th, 2021
alcami acquires Masy Systems Inc.

Alcami Corp., a pharmaceutical and biotech contract development and manufacturing organization ( CDMO ), has completed the acquisition of Masy Systems Inc., a provider of cGMP biostorage and pharma support services.

PR Newswire
Dec 15th, 2021
AAIPharma Services Corp. acquired Masy Systems Inc. on Dec 15th 21'.

Alcami Corporation, a leading pharmaceutical and biotech contract development and manufacturing organization (CDMO), announced today it has completed the acquisition of Masy Systems Inc. ("Masy" or "Masy BioServices"), a preferred provider of cGMP Biostorage and pharma support services.

Daily Times Chronicle
Dec 1st, 2021
Masy Systems Inc. launches SenseAnywhere modules

Masy BioServices announces the launch of innovative SenseAnywhere modules.